Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown BioLineRx Ltd. BLRX

BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the...


Top institutional share ownership of BioLineRx Ltd.

Name Shares Shares % change Value Value % change
Altium Capital Management LP 4,149,262 $3,838
Sabby Management, Llc 3,034,107 $2,807
Armistice Capital, Llc 2,797,048 $2,587
DFIEX - International Core Equity Portfolio - Institutional Class 391,980 0.0% $23 -32.4%
Parkman Healthcare Partners LLC 288,852 1.2% $267 -26.9%
Morgan Stanley 262,559 4.1% $243 -24.8%
MJ - ETFMG Alternative Harvest ETF 241,843 $196
DFA INVESTMENT DIMENSIONS GROUP INC - International Vector Equity Portfolio Shares 118,855 0.0% $11 0.0%
DFA INVESTMENT DIMENSIONS GROUP INC - World ex U.S. Targeted Value Portfolio Institutional Class 116,032 0.0% $7 -40.0%
Atria Wealth Solutions, Inc. 104,032 0.0% $96 -27.8%

Top institutional buyers of BioLineRx Ltd.

Name Shares % change Value % change Shares Value
Virtu Financial LLC 195.6% 115.0% 46,168 $43
Renaissance Technologies Llc 49.1% 6.8% 68,222 $63
Morgan Stanley 4.1% -24.8% 262,559 $243
Parkman Healthcare Partners LLC 1.2% -26.9% 288,852 $267

Top institutional sellers of BioLineRx Ltd.

Name Shares % change Value % change Shares Value
Pvg Asset Management Corp -70.2% -86.5% 47,860 $44
Envestnet Asset Management Inc -41.9% -57.6% 29,839 $28
LPL Financial LLC -7.9% -33.9% 46,576 $43
DFA INVESTMENT DIMENSIONS GROUP INC - International Social Core Equity Portfolio Institutional Class -7.3% -42.9% 74,641 $4

Information provided by Fintel.io